Barbara Jenko

NLRP3 and CARD8 Polymorphisms Influence Higher Disease Activity in Rheumatoid Arthritis

Barbara Jenko, Sonja Praprotnik, Matija Tomšič et al. · Journal of Medical Biochemistry · 2016 · 55 citations · Full text

Clinical Pharmacogenetic Models of Treatment Response to Methotrexate Monotherapy in Slovenian and Serbian Rheumatoid Arthritis Patients: Differences in Patient's Management May Preclude Generalization of the Models

Barbara Jenko, Matija Tomšič, Biljana Jekić et al. · Frontiers in Pharmacology · 2018 · 32 citations · Full text

Detection of metabolic syndrome burden in healthy young adults may enable timely introduction of disease prevention

Anja Šoštarič, Barbara Jenko, Nada Rotovnik Kozjek et al. · Archives of Medical Science · 2019 · 31 citations · Full text

Clinical–pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis

Barbara Jenko, Lara Lusa, Matija Tomšič et al. · The Pharmacogenomics Journal · 2016 · 16 citations

Rheumatoid Disorder, Rheumatology, Adverse Events +9

Survivin Polymorphism is Associated with Disease Activity in Rheumatoid Arthritis Patients

Barbara Jenko, Sonja Praprotnik, Saša Čučnik et al. · Pharmacogenomics · 2015 · 12 citations